Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine PK in Elderly Breast and Colorectal Cancer
NCT03465202Phase 4Unknown
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- May 2016
- Primary completion
- May 2018
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
01
Overview
A Phase 4 trial of capecitabine in breast cancer, colorectal cancer (CRC), sponsored by Newcastle Hospitals NHS Foundation Trust. Status: unknown.
02
Drugs
capecitabine
03
Conditions
breast cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03465202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03465202.